Cargando…

Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()

Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi-Naini, Ali, Sofroni, Ervis, Papanicolau, Naum, Falou, Omar, Sugar, Linda, Morton, Gerard, Yaffe, Martin J., Nam, Robert, Sadeghian, Alireza, Kolios, Michael C., Chung, Hans T., Czarnota, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350638/
https://www.ncbi.nlm.nih.gov/pubmed/25749174
http://dx.doi.org/10.1016/j.tranon.2014.11.005
_version_ 1782360213552103424
author Sadeghi-Naini, Ali
Sofroni, Ervis
Papanicolau, Naum
Falou, Omar
Sugar, Linda
Morton, Gerard
Yaffe, Martin J.
Nam, Robert
Sadeghian, Alireza
Kolios, Michael C.
Chung, Hans T.
Czarnota, Gregory J.
author_facet Sadeghi-Naini, Ali
Sofroni, Ervis
Papanicolau, Naum
Falou, Omar
Sugar, Linda
Morton, Gerard
Yaffe, Martin J.
Nam, Robert
Sadeghian, Alireza
Kolios, Michael C.
Chung, Hans T.
Czarnota, Gregory J.
author_sort Sadeghi-Naini, Ali
collection PubMed
description Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients with prostate cancer underwent a volumetric transrectal ultrasound scan before radical prostatectomy. Conventional-frequency (~ 5 MHz) ultrasound images and radiofrequency data were collected from patients. Normalized power spectra were used as the basis of quantitative ultrasound spectroscopy. Specifically, color-coded parametric maps of 0-MHz intercept, midband fit, and spectral slope were computed and used to characterize prostate tissue in ultrasound images. Areas of cancer were identified in whole-mount histopathology specimens, and disease extent was correlated to that estimated from quantitative ultrasound parametric images. Midband fit and 0-MHz intercept parameters were found to be best associated with the presence of disease as located on histopathology whole-mount sections. Obtained results indicated a correlation between disease extent estimated noninvasively based on midband fit parametric images and that identified histopathologically on prostatectomy specimens, with an r(2) value of 0.71 (P < .0001). The 0-MHz intercept parameter demonstrated a lower level of correlation with histopathology. Spectral slope parametric maps offered no discrimination of disease. Multiple regression analysis produced a hybrid disease characterization model (r(2) = 0.764, P < .05), implying that the midband fit biomarker had the greatest correlation with the histopathologic extent of disease. This work demonstrates that quantitative ultrasound spectroscopic imaging can be used for detecting prostate cancer and characterizing disease extent noninvasively, with corresponding gross three-dimensional histopathologic correlation.
format Online
Article
Text
id pubmed-4350638
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-43506382015-03-09 Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() Sadeghi-Naini, Ali Sofroni, Ervis Papanicolau, Naum Falou, Omar Sugar, Linda Morton, Gerard Yaffe, Martin J. Nam, Robert Sadeghian, Alireza Kolios, Michael C. Chung, Hans T. Czarnota, Gregory J. Transl Oncol Article Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients with prostate cancer underwent a volumetric transrectal ultrasound scan before radical prostatectomy. Conventional-frequency (~ 5 MHz) ultrasound images and radiofrequency data were collected from patients. Normalized power spectra were used as the basis of quantitative ultrasound spectroscopy. Specifically, color-coded parametric maps of 0-MHz intercept, midband fit, and spectral slope were computed and used to characterize prostate tissue in ultrasound images. Areas of cancer were identified in whole-mount histopathology specimens, and disease extent was correlated to that estimated from quantitative ultrasound parametric images. Midband fit and 0-MHz intercept parameters were found to be best associated with the presence of disease as located on histopathology whole-mount sections. Obtained results indicated a correlation between disease extent estimated noninvasively based on midband fit parametric images and that identified histopathologically on prostatectomy specimens, with an r(2) value of 0.71 (P < .0001). The 0-MHz intercept parameter demonstrated a lower level of correlation with histopathology. Spectral slope parametric maps offered no discrimination of disease. Multiple regression analysis produced a hybrid disease characterization model (r(2) = 0.764, P < .05), implying that the midband fit biomarker had the greatest correlation with the histopathologic extent of disease. This work demonstrates that quantitative ultrasound spectroscopic imaging can be used for detecting prostate cancer and characterizing disease extent noninvasively, with corresponding gross three-dimensional histopathologic correlation. Neoplasia Press 2015-03-03 /pmc/articles/PMC4350638/ /pubmed/25749174 http://dx.doi.org/10.1016/j.tranon.2014.11.005 Text en © 2014 Neoplasia Press, Inc. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Sadeghi-Naini, Ali
Sofroni, Ervis
Papanicolau, Naum
Falou, Omar
Sugar, Linda
Morton, Gerard
Yaffe, Martin J.
Nam, Robert
Sadeghian, Alireza
Kolios, Michael C.
Chung, Hans T.
Czarnota, Gregory J.
Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title_full Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title_fullStr Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title_full_unstemmed Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title_short Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
title_sort quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350638/
https://www.ncbi.nlm.nih.gov/pubmed/25749174
http://dx.doi.org/10.1016/j.tranon.2014.11.005
work_keys_str_mv AT sadeghinainiali quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT sofroniervis quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT papanicolaunaum quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT falouomar quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT sugarlinda quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT mortongerard quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT yaffemartinj quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT namrobert quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT sadeghianalireza quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT koliosmichaelc quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT chunghanst quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients
AT czarnotagregoryj quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients